Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;117(3):507-14.
doi: 10.1111/bju.13059. Epub 2015 May 15.

Causes of death in men with localized prostate cancer: a nationwide, population-based study

Affiliations

Causes of death in men with localized prostate cancer: a nationwide, population-based study

Mieke Van Hemelrijck et al. BJU Int. 2016 Mar.

Abstract

Objective: To detail the distribution of causes of death from localized prostate cancer (PCa).

Patients and methods: The database PCBase Sweden links the Swedish National Prostate Cancer Register with other nationwide population-based healthcare registers. We selected all 57 187 men diagnosed with localized PCa between 1997 and 2009 and their 114 374 PCa-free control subjects, matched according to age and county of residence. Mortality was calculated using competing risk regression analyses, taking into account PCa risk category, age and Charlson comorbidity index (CCI).

Results: In men with low-risk PCa, all-cause mortality was lower compared with that in corresponding PCa-free men: 10-year all-cause mortality was 18% for men diagnosed at age 70 years, with a CCI score of 0, and 21% among corresponding control subjects. Of these cases, 31% died from cardiovascular disease (CVD) compared with 37% of the corresponding control subjects. For men with low-risk PCa, 10-year PCa-mortality was 0.4, 1 and 3% when diagnosed at age 50, 60 and 70 years, respectively. PCa was the third most common cause of death (18%), after CVD (31%) and other cancers (30%). By contrast, PCa was the most common cause of death in men with intermediate- and high-risk localized PCa.

Conclusions: Men with low-risk PCa had lower all-cause mortality than PCa-free men because of lower CVD mortality, driven by early detection selection; however, for men with intermediate- or high-risk disease, the rate of PCa death was substantial, irrespective of CCI score, and this was even more pronounced for those diagnosed at age 50 or 60 years.

Keywords: comorbidities; curative treatment; localized disease; prostate cancer death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Predicted risk of death 10 years after prostate cancer (PCa) diagnosis for men aged 50, 60, and 70 years at date of diagnosis, by PCa risk category and Charlson comorbidity index (CCI). The risk of death from all causes is represented by the size of the pie charts. Each section of the pies represents the proportion of men who died from a specific cause estimated with Fine and Gray analyses.

References

    1. Neppl‐Huber C, Zappa M, Coebergh JW et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol 2012; 23: 1325–34 - PubMed
    1. Popiolek M, Rider JR, Andren O et al. Natural history of early, localized prostate cancer: a final report from three decades of follow‐up. Eur Urol 2012; 23084329 - PubMed
    1. Rider JR, Sandin F, Andren O, Wiklund P, Hugosson J, Stattin P. Long‐term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide. Population‐based Study. Eur Urol 2013; 63: 88–96 - PubMed
    1. Holmstrom B, Holmberg E, Egevad L et al. Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow‐Up Study. J Urol 2010; 184: 1322–7 - PubMed
    1. Stattin P, Holmberg E, Johansson J, Holmberg L, Adolfsson J, Hugosson J. Outcomes for men with localized prostate cancer in the National Prostate Cancer Register (NPCR) of Sweden. J Natl Cancer Inst 2010; 102: 950–8 - PMC - PubMed

Publication types